drugset / Trial / NCT06820320

Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

NCT06820320

NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to assess the effectiveness of oral iohexol in the treatment of postoperative chylous ascites. It will also learn about the safety of oral iohexol. The main questions it aims to answer are: * Confirm the potential of oral iohexol as an innovative therapeutic regimen. * Confirm its ability to improve clinical outcomes for patients.

Timeline

Start
2025-02-15
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Iohexol Diagnostic / imaging agent Oral